Scientists at MIT and Stanford have unveiled a promising new way to help the immune system recognize and attack cancer cells ...

Expression of co-inhibitory receptors or “checkpoint” molecules, such as CTLA-4 and PD-1, on effector T cells is a key mechanism for ensuring immune homeostasis. Dysregulated expression of ...

Scientists showed that using new molecules that block an immune "checkpoint" could stimulate a "strong" anti-tumor immune ...

Researchers demonstrated that newly developed molecules designed to block an immune checkpoint can trigger a powerful immune response against tumors. Scientists at MIT and Stanford University have ...

New research has uncovered immune changes in cancer patients that could help identify which patients are most at risk of dangerous heart complications from cancer drugs, known as immune checkpoint ...

The process of identifying promising small molecule drug candidates that target cancer checkpoints may become faster and smarter through virtual screening, according to Weill Cornell Medicine ...

Recent research highlights an approach in cancer therapy with small molecule drugs targeting immune checkpoints. These innovative drugs overcome the limitations of antibody-based inhibitors, such as ...

A research collaboration between MIT and Stanford has developed a new approach intended to help the immune system recognise and attack tumours more effectively. Instead of focusing only on protein ...

RNA is usually portrayed as a molecule that works deep inside the cell, helping to turn genetic information into proteins.

MIRAMAR, Fla., Nov. 10, 2025 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (the “Company” or “HCW Biologics”), (NASDAQ: HCWB), a U.S.-based clinical-stage biopharmaceutical company focused on discovering and ...

Cancer has a talent for hiding in plain sight, cloaking itself in sugary molecules that convince the immune system to stand ...